NCT03538587View on ClinicalTrials.gov

Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 29, 2019

Primary Completion Date

September 13, 2022

Study Completion Date

September 13, 2022

Conditions
GlioblastomasSarcomaAstrocytomaBrain CancerLeukemia
Interventions
BEHAVIORAL

Enhanced Mindfulness Intervention

"The 8-week EMI will consist of one initial in-person session with the participant and parent, a series of at home assignments, and two booster sessions. The psychoeducation group will be given educational material about coping with cancer."

BEHAVIORAL

Psychoeducation

The psychoeducation group will be offered the opportunity to participate in the EMI 8 weeks post-baseline.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT03538587 - Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers | Biotech Hunter | Biotech Hunter